Angiotensin II: breathtaking in the renal medulla

Slides:



Advertisements
Similar presentations
Von Hippel-Lindau Syndrome
Advertisements

Volume 84, Issue 3, Pages (September 2013)
Targeting HIF2α in Clear-Cell Renal Cell Carcinoma
Volume 76, Issue 9, Pages (November 2009)
HIF1a Pathway ProteinLounge.com Glucose Glucose Glucose Transporter
Nat. Rev. Nephrol. doi: /nrneph
HIFs: a-cute answer to inflammation?
Volume 88, Issue 5, Pages (November 2015)
Toshio Miyata, Norio Suzuki, Charles van Ypersele de Strihou 
Volume 82, Issue 1, Pages 7-8 (July 2012)
Sirtuins and the Metabolic Hurdles in Cancer
Hypoxia, Hypoxia-inducible Transcription Factors, and Renal Cancer
Hypoxia-Inducible Factors Link Iron Homeostasis and Erythropoiesis
Volume 11, Issue 4, Pages (April 2007)
The VHL/HIF oxygen-sensing pathway and its relevance to kidney disease
Management of advanced renal cancer
PK-M2 Makes Cells Sweeter on HIF1
Driving change: kidney proximal tubule CSF-1 polarizes macrophages
Basic Research in Kidney Cancer
Functional evidence confirmed by histological localization: overlapping expression of erythropoietin and HIF-2α in interstitial fibroblasts of the renal.
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Role of hypoxia in the pathogenesis of renal disease
Molecular mechanisms of diabetic renal hypertrophy
Hamid R. Rezvani, Nsrein Ali, Lars J
Hypoxia inducible factors in liver disease and hepatocellular carcinoma: Current understanding and future directions  Garrick K. Wilson, Daniel A. Tennant,
EGFR signaling in renal fibrosis
Volume 79, Issue 3, Pages (February 2011)
Renoprotective effects of vitamin D analogs
JAK/STAT signaling in renal diseases
ANO1: an additional key player in cyst growth
Targeting HIF2α in Clear-Cell Renal Cell Carcinoma
Volume 76, Issue 9, Pages (November 2009)
Volume 84, Issue 3, Pages (September 2013)
The Hypoxic Response: Huffing and HIFing
Y. Henrotin, Ph.D., B. Kurz, Ph.D., T. Aigner, M.D.DSc. 
Yasemin Sirin, Hermann Pavenstädt  Kidney International 
Volume 70, Issue 7, Pages (October 2006)
Volume 107, Issue 1, Pages 1-3 (October 2001)
Mechanism of steroid action in renal epithelial cells
Weei-Yuarn Huang, Seymour Rosen  Kidney International 
Into Thin Air: How We Sense and Respond to Hypoxia
ARNT as a Novel Antifibrotic Target in CKD
Volume 70, Issue 10, Pages (November 2006)
Passing the baton: the HIF switch
Nitric oxide and vascular remodeling: Spotlight on the kidney
Macrophages and hypoxia in human chronic kidney disease
Volume 78, Issue 8, Pages (October 2010)
Insight from the Air–Skin Interface
Regulation of the Immune Response by the Aryl Hydrocarbon Receptor
Low oxygen stimulates the immune system
Driving change: kidney proximal tubule CSF-1 polarizes macrophages
Volume 69, Issue 3, Pages (February 2006)
Matrix metalloproteinases and matrix receptors in progression and reversal of kidney disease: therapeutic perspectives  Pierre Ronco, Christos Chatziantoniou 
Juan Camilo Duque, Roberto I. Vazquez-Padron  Kidney International 
EMT and proteinuria as progression factors
Hydrogen: another gas with therapeutic potential
Volume 78, Issue 1, Pages (July 2010)
Inflammation and hypoxia in the kidney: friends or foes?
Volume 73, Issue 5, Pages (March 2008)
Molecular mechanisms of renal hypertrophy: Role of p27Kip1
Hypoxia and fibrosis in chronic kidney disease: crossing at pericytes
Volume 82, Issue 6, Pages (September 2012)
Volume 76, Issue 5, Pages (September 2009)
Role of immunocompetent cells in nonimmune renal diseases
Regulation of Intestinal Iron Absorption: The Mucosa Takes Control?
Sundararaman Swaminathan, Matthew D. Griffin  Kidney International 
PK-M2 Makes Cells Sweeter on HIF1
Schematic diagram of the HIF-signalling system and zebrafish homologues. Schematic diagram of the HIF-signalling system and zebrafish homologues. (A) Proteins.
Update on the Medical Treatment of Metastatic Renal Cell Carcinoma
ROS: Really involved in Oxygen Sensing
Presentation transcript:

Angiotensin II: breathtaking in the renal medulla Volker H. Haase  Kidney International  Volume 79, Issue 3, Pages 269-271 (February 2011) DOI: 10.1038/ki.2010.434 Copyright © 2011 International Society of Nephrology Terms and Conditions

Figure 1 Angiotensin II stabilizes hypoxia-inducible factor-1α in renal medullary interstitial cells. Angiotensin II (Ang II) stimulates the production of reactive oxygen species (ROS). This leads to the inhibition of the hypoxia-inducible factor (HIF)-hydroxylation reaction and subsequent stabilization of HIF-1α. HIF-1α is required for Ang II-induced profibrotic gene expression and proliferation of renal medullary interstitial cells. Under normoxia, HIF-1α is normally hydroxylated by prolyl-4-hydroxylases and targeted for proteasomal degradation by the von Hippel-Lindau (pVHL)–E3 ubiquitin ligase complex. When prolyl-4-hydroxylation is inhibited, HIF-1α is stabilized and translocates to the nucleus, where it heterodimerizes with the aryl hydrocarbon receptor nuclear translocator (ARNT). HIF-1α–ARNT heterodimers bind to the HIF consensus-binding site RCGTG, followed by transactivation of target genes. In addition to ROS, nitric oxide, the Krebs cycle metabolites succinate and fumarate, cobalt chloride, and iron chelators such as desferrioxamine inhibit HIF prolyl-4-hydroxylases in the presence of oxygen. CoCl2, cobalt chloride; Fe2+, ferrous iron; NO, nitric oxide; P-4-HD, prolyl-4-hydroxylases; TIMP-1, tissue inhibitor of metalloproteinases-1. Kidney International 2011 79, 269-271DOI: (10.1038/ki.2010.434) Copyright © 2011 International Society of Nephrology Terms and Conditions